Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term omalizumab efficacy in allergic rhinitis.
Cavaliere C, Begvarfaj E, Incorvaia C, Sposato B, Brunori M, Ciofalo A, Greco A, de Vincentiis M, Masieri S. Cavaliere C, et al. Among authors: sposato b. Immunol Lett. 2020 Nov;227:81-87. doi: 10.1016/j.imlet.2020.08.002. Epub 2020 Aug 13. Immunol Lett. 2020. PMID: 32798500 Free article.
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes.
Sposato B, Scalese M, Milanese M, Masieri S, Cavaliere C, Latorre M, Scichilone N, Ricci A, Cresti A, Santus P, Olivieri C, Perrella A, Rogliani P, Paggiaro P; Omalizumab Italian Study Group. Sposato B, et al. J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1643-1646. doi: 10.1016/j.jaip.2019.03.006. Epub 2019 Mar 19. J Allergy Clin Immunol Pract. 2019. PMID: 30898690 No abstract available.
Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life.
Sposato B, Camiciottoli G, Bacci E, Scalese M, Carpagnano GE, Pelaia C, Santus P, Maniscalco M, Masieri S, Corsico A, Scichilone N, Baglioni S, Murgia N, Folletti I, Bardi G, Grosso A, Cameli P, Latorre M, Musarra A, Bargagli E, Ricci A, Pelaia G, Paggiaro P, Rogliani P. Sposato B, et al. Pulm Pharmacol Ther. 2020 Apr;61:101899. doi: 10.1016/j.pupt.2020.101899. Epub 2020 Jan 21. Pulm Pharmacol Ther. 2020. PMID: 31972327
Mepolizumab Effectiveness and Allergic Status in Real Life.
Sposato B, Scalese M, Camiciottoli G, Carpagnano GE, Pelaia C, Santus P, Maniscalco M, Corsico A, Grosso A, Baglioni S, Murgia N, Folletti I, Pelaia G, Masieri S, Cavaliere C, Musarra A, Bargagli E, Ricci A, Latorre M, Paggiaro P, Rogliani P. Sposato B, et al. Int Arch Allergy Immunol. 2021;182(4):311-318. doi: 10.1159/000511147. Epub 2020 Oct 28. Int Arch Allergy Immunol. 2021. PMID: 33113532
Severe asthma and long-term Benralizumab effectiveness in real-life.
Sposato B, Scalese M, Camiciottoli G, Carpagnano GE, Pelaia C, Santus P, Pelaia G, Palmiero G, Di Tomassi M, Ronchi MC, Cameli P, Bargagli E, Ciambellotti L, Rizzello S, Sglavo R, Coppola A, Lacerenza LG, Gabriele M, Radovanovic D, Perrella A, Ricci A, Rogliani P. Sposato B, et al. Eur Rev Med Pharmacol Sci. 2022 Oct;26(20):7461-7473. doi: 10.26355/eurrev_202210_30016. Eur Rev Med Pharmacol Sci. 2022. PMID: 36314316 Free article.
Which LABA/LAMA should be chosen in COPD patients in real life?
Sposato B, Petrucci E, Serafini A, Lena F, Lacerenza LG, Montagnani A, Alessandri M, Cresti A, Scala R, Rogliani P, Ricci A, Perrella A, Scalese M. Sposato B, et al. Pulm Pharmacol Ther. 2021 Dec;71:102076. doi: 10.1016/j.pupt.2021.102076. Epub 2021 Sep 13. Pulm Pharmacol Ther. 2021. PMID: 34530132
96 results